Abiopharma

News list

Director KLOSK STEVEN M 🟢 acquired 30.5K shares of LISATA THERAPEUTICS, INC. (LSTA) Transaction Date: Jan 09, 2026 | Filing ID: 000004

Full text

News bot Jan. 13, 2026, 9:15 p.m.
🔍 KLOSK STEVEN M (Director)

Company: LISATA THERAPEUTICS, INC. (LSTA)

Report Date: 2026-01-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 30,456
Detailed Transactions and Holdings:
- Acquired 30,456 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 95,815.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents 30,456 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2027.
- F2: Includes 30,456 unvested restricted stock units.